Skip to main content
Top

Seminars in Immunopathology

Issue 2/2010

T-cell Signaling and Immunopathology / Guest Edited by Christopher E. Rudd

Content (11 Articles)

Editorial

T-cell signaling and immunopathologies

Christopher E. Rudd

Review

ZAP70: a master regulator of adaptive immunity

Alain Fischer, Capucine Picard, Karine Chemin, Stéphanie Dogniaux, Françoise le Deist, Claire Hivroz

Review

Lymphoproliferative disorders involving T helper effector cells with defective LAT signalosomes

Romain Roncagalli, Michael Mingueneau, Claude Grégoire, Christelle Langlet, Bernard Malissen, Marie Malissen

Review

Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases

Stephanie M. Stanford, Tomas M. Mustelin, Nunzio Bottini

Review

Cbl-b in T-cell activation

Magdalena Paolino, Josef M. Penninger

Review

SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions

Cynthia Detre, Marton Keszei, Xavier Romero, George C. Tsokos, Cox Terhorst

Review

Immunopathologies linked to integrin signalling

Hongyan Wang, Daina Lim, Christopher E. Rudd

Latest issues

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine